Reviva Pharmaceuticals Holdings, Inc. (RVPHW)

Market Cap	27.56M
Revenue (ttm)	n/a
Net Income (ttm)	-28.92M
Shares Out	46.74M
EPS (ttm)	-0.76
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,731
Open	0.0350
Previous Close	0.0350
Day's Range	0.0327 - 0.0392
52-Week Range	0.0226 - 0.7800
Beta	0.11
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 14, 2025

About RVPHW

Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company’s lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dem...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2018
• Employees: 14
• Stock Exchange: NASDAQ
• Ticker Symbol: RVPHW
• Website: https://www.revivapharma.com